These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12058808)

  • 1. Influence of processing conditions in the manufacture of O/W creams: II. Effect on drug availability.
    Realdon N; Ragazzi E; Morpurgo M; Ragazzi E
    Farmaco; 2002 May; 57(5):349-53. PubMed ID: 12058808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of processing conditions in the manufacture of O/W creams: I. Effect on dispersion grade and rheological characteristics.
    Realdon N; Perin F; Morpurgo M; Ragazzi E
    Farmaco; 2002 May; 57(5):341-7. PubMed ID: 12058807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of release and simulated absorption of methyl nicotinate from different ointment formulations: in vitro-in vivo correlations.
    Realdon N; Ragazzi E; Dal Zotto M; Ragazzi E
    Pharmazie; 1996 Feb; 51(2):113-6. PubMed ID: 8720806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents.
    Remane Y; Leopold CS
    Skin Pharmacol Physiol; 2006; 19(6):303-10. PubMed ID: 16931897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilizing effect of cetostearyl alcohol and glyceryl monostearate as co-emulsifiers on hydrocarbon-free O/W glyceride creams.
    Ballmann C; Mueller BW
    Pharm Dev Technol; 2008; 13(5):433-45. PubMed ID: 18728995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles.
    Puglia C; Esposito E; Menegatti E; Nastruzzi C; Rizza L; Cortesi R; Bonina F
    J Pharm Pharmacol; 2005 Sep; 57(9):1169-76. PubMed ID: 16105237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of microemulsion formulations of nicotinic acid and its prodrugs for transdermal delivery.
    Tashtoush BM; Bennamani AN; Al-Taani BM
    Pharm Dev Technol; 2013; 18(4):834-43. PubMed ID: 23030413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the Supramolecular Micro-Assembly of Multiple Emulsions on their Biopharmaceutical Features and In vivo Therapeutic Response.
    Cilurzo F; Cristiano MC; Di Marzio L; Cosco D; Carafa M; Ventura CA; Fresta M; Paolino D
    Curr Drug Targets; 2015; 16(14):1612-22. PubMed ID: 26601721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of microemulsion and microemulsion gel formulations for dermal delivery of clotrimazole.
    Zhang J; Michniak-Kohn BB
    Int J Pharm; 2018 Jan; 536(1):345-352. PubMed ID: 29170117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New microemulsion vehicle facilitates percutaneous penetration in vitro and cutaneous drug bioavailability in vivo.
    Sintov AC; Shapiro L
    J Control Release; 2004 Mar; 95(2):173-83. PubMed ID: 14980766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-emulsifying pellets prepared by wet granulation in high-shear mixer: influence of formulation variables and preliminary study on the in vitro absorption.
    Franceschinis E; Voinovich D; Grassi M; Perissutti B; Filipovic-Grcic J; Martinac A; Meriani-Merlo F
    Int J Pharm; 2005 Mar; 291(1-2):87-97. PubMed ID: 15707735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
    Realdon N; Tagliaboschi A; Perin F; Ragazzi E
    Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation.
    Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC
    Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheological, mechanical and membrane penetration properties of novel dual drug systems for percutaneous delivery.
    Woolfson AD; Malcolm RK; Campbell K; Jones DS; Russell JA
    J Control Release; 2000 Jul; 67(2-3):395-408. PubMed ID: 10825570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of bioavailability by lowering of fat content in topical formulations.
    Wirén K; Frithiof H; Sjöqvist C; Lodén M
    Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viscoelastic properties of a virucidal cream containing the monoglyceride monocaprin: effects of formulation variables: a technical note.
    Thorgeirsdóttir TO; Thormar H; Kristmundsdóttir T
    AAPS PharmSciTech; 2006 May; 7(2):E44. PubMed ID: 16796361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel microemulsion-based gel formulation of tazarotene for therapy of acne.
    Patel MR; Patel RB; Parikh JR; Patel BG
    Pharm Dev Technol; 2016 Dec; 21(8):921-932. PubMed ID: 26334480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.
    Djekic L; Primorac M
    Int J Pharm; 2008 Mar; 352(1-2):231-9. PubMed ID: 18068919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of nutraceutical coenzyme Q10 nanoemulsion with improved skin permeability and anti-wrinkle efficiency.
    El-Leithy ES; Makky AM; Khattab AM; Hussein DG
    Drug Dev Ind Pharm; 2018 Feb; 44(2):316-328. PubMed ID: 29096550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a prospective isopropyl alcohol-loaded pharmaceutical base using simultaneous in vitro/in vivo characterization methods of skin performance.
    Pantelic I; Lukic M; Markovic B; Lusiana ; Hoffmann C; Müller-Goymann C; Milic J; Daniels R; Savic S
    Drug Dev Ind Pharm; 2014 Jul; 40(7):960-71. PubMed ID: 23688275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.